ProQR Therapeutics is a clinical-stage biotech company listed on NASDAQ with offices in Leiden, the Netherlands and Cambridge, MA, US. ProQR is focused on the development of game changing RNA therapies for severe genetic rare diseases. Our mission is to help patients by creating new medicines. A team of 140 ProQRians from all walks of life and more than 30 different nationalities is up to the challenge. We have the passion and commitment to make a difference in the lives of the patients we serve.